1. Home
2. Education & On demand
3. Quality Improvement

Quality Improvement (QI) Programmes

The PCCS QI programmes comprise of a number of educational resources and is designed to support primary healthcare teams to enhance the quality of care delivered to patients with cardiovascular disease. 

Take a further look here: 

• Triglycerides Quality Improvement Programme

This programme has been funded by Amarin Corp plc. Amarin were not involved in the development of the programme, content, selection of speakers or their arrangements. All content has been independently developed by the PCCS.

• COVID-19 Quality Improvement Programme 

This programme has been funded by Pfizer Ltd by an independent medical educational grant. Pfizer were not involved in the development of the programme, content, selection of speakers or their arrangements. All content has been independently developed by the PCCS.

• Chronic Kidney Disease Quality Improvement Programme

This programme was solely funded by Bayer PLC. Bayer PLC were not involved in the development of the programme, content, selection of speakers or their arrangements. All content was independently developed by PCCS.

• Lipid Quality Improvement (QI) Programme

This programme has been solely funded by Novartis. Novartis were not involved in the development of the programme, content, selection of speakers or their arrangements. All content has been independently developed by PCCS.